Guardian Pharmacy Services, Inc. Cost of Revenue
Guardian Pharmacy Services, Inc. (GRDN) reported Cost of Revenue of $271.72 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-06
- Guardian Pharmacy Services, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $271.72M, a 1.62% decline year-over-year.
- Guardian Pharmacy Services, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $260.29M, a 1.76% decline year-over-year.
- Guardian Pharmacy Services, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $312.11M, a 14.97% increase year-over-year.
- Guardian Pharmacy Services, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $302.71M, a 19.40% increase year-over-year.
- Guardian Pharmacy Services, Inc. cost of goods and services sold for fiscal 2025 was $1.16B, a 17.47% increase from fiscal 2024.
- Guardian Pharmacy Services, Inc. cost of goods and services sold for fiscal 2024 was $984.04M.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $271.72M 10-Q · filed 2026-08-06 | $532.01M 10-Q · filed 2026-08-06 | $844.12M derived: sum of 3 quarters · filed 2026-08-06 | $1.15B derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $260.29M 10-Q · filed 2026-05-06 | $572.40M derived: sum of 2 quarters · filed 2026-05-06 | $875.11M derived: sum of 3 quarters · filed 2026-05-06 | $1.15B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $312.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $614.82M derived: sum of 2 quarters · filed 2026-03-11 | $891.01M derived: sum of 3 quarters · filed 2026-08-06 | $1.16B 10-K · filed 2026-03-11 |
| 2025-09-30 | $302.71M 10-Q · filed 2025-11-10 | $578.89M derived: sum of 2 quarters · filed 2026-08-06 | $843.85M 10-Q · filed 2025-11-10 | $1.12B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $276.19M 10-Q · filed 2026-08-06 | $541.15M 10-Q · filed 2026-08-06 | $812.61M derived: sum of 3 quarters · filed 2026-08-06 | $1.07B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $264.96M 10-Q · filed 2026-05-06 | $536.42M derived: sum of 2 quarters · filed 2026-05-06 | $789.94M derived: sum of 3 quarters · filed 2026-05-06 | $1.03B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $271.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $524.98M derived: sum of 2 quarters · filed 2026-03-11 | $763.73M derived: sum of 3 quarters · filed 2026-03-11 | $984.04M 10-K · filed 2026-03-11 |
| 2024-09-30 | $253.51M 10-Q · filed 2025-11-10 | $492.26M derived: sum of 2 quarters · filed 2025-11-10 | $712.57M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $238.75M 10-Q · filed 2025-08-11 | $459.06M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $220.31M 10-Q · filed 2025-05-12 | |||
| 2023-09-30 | $210.55M 10-Q · filed 2024-11-12 | $611.39M 10-Q · filed 2024-11-12 |